Ainos (NASDAQ:AIMD) Director Chun-Jung Tsai Sells 27,718 Shares

Ainos, Inc. (NASDAQ:AIMD) Director Chun-Jung Tsai sold 27,718 shares of the company’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $1.87, for a total value of $51,832.66. Following the sale, the director owned 658,199 shares in the company, valued at approximately $1,230,832.13. This represents a 4.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Chun-Jung Tsai also recently made the following trade(s):

• On Friday, May 22nd, Chun-Jung Tsai sold 1,082 shares of Ainos stock. The shares were sold at an average price of $1.55, for a total value of $1,677.10.

Ainos Price Performance

Shares of AIMD traded down $0.60 during midday trading on Wednesday, hitting $2.56. 1,873,740 shares of the company traded hands, compared to its average volume of 893,030. The stock has a 50-day moving average of $1.67 and a 200-day moving average of $1.83. Ainos, Inc. has a one year low of $1.26 and a one year high of $4.50. The firm has a market cap of $21.81 million, a P/E ratio of -0.89 and a beta of 2.29. The company has a debt-to-equity ratio of 1.58, a current ratio of 0.55 and a quick ratio of 0.50.

Ainos (NASDAQ:AIMD) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter. Ainos had a negative net margin of 11,912.10% and a negative return on equity of 160.55%.

Hedge Funds Weigh In On Ainos

A number of hedge funds and other institutional investors have recently bought and sold shares of AIMD. Mariner LLC purchased a new position in Ainos in the 4th quarter worth approximately $37,000. Two Sigma Investments LP purchased a new position in Ainos in the 3rd quarter worth approximately $80,000. DRW Securities LLC grew its stake in Ainos by 272.6% in the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after buying an additional 48,439 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in Ainos by 13.1% in the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after buying an additional 7,700 shares in the last quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Ainos currently has an average rating of “Sell”.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.